Insider Transactions Reported by 9 Insiders of 9 METERS BIOPHARMA, INC.

Location
Raleigh, NC

There are no Buy or Sell transactions made by insiders since 13 Mar 2025

9 METERS BIOPHARMA, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
OrbiMed Israel GP Ltd. 10%+ Owner $1,950,472 23 Jun 2021
Edward J. Sitar Chief Financial Officer $44,251 14 Sep 2021
John Temperato Chief Executive Officer, Director $31,922 27 Mar 2023
Mark A. Sirgo Director $19,806 29 Mar 2023
Bethany Sensenig Chief Financial Officer $9,353 21 Apr 2023
Lorin K. Johnson Director $2,761 29 Mar 2023
Constantino Michael T. Director $2,484 29 Mar 2023
Yehuda Michael Rice Director $1,795 29 Mar 2023
Samantha Ventimiglia Director $1,795 29 Mar 2023

Recent Insider Transactions by Companies or Individuals for 9 METERS BIOPHARMA, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Bethany Sensenig Common stock Sale -18.1% -9,100 41,077 21 Apr 2023 Direct
Yehuda Michael Rice Common Stock Award 7,885 7,885 29 Mar 2023 Direct
Constantino Michael T. Common Stock Award 260.6% 7,885 10,911 29 Mar 2023 Direct
Samantha Ventimiglia Common Stock Award 7,885 7,885 29 Mar 2023 Direct
Mark A. Sirgo Common Stock Award 10.1% 7,885 85,907 29 Mar 2023 Direct
Lorin K. Johnson Common Stock Award 186% 7,885 12,125 29 Mar 2023 Direct
Bethany Sensenig Common Stock Award 50,177 50,177 27 Mar 2023 Direct
John Temperato Common Stock Award 96.4% 68,815 140,192 27 Mar 2023 Direct
John Temperato Common stock Purchase 9.6% $28,462 $0.2277 125,000 1,427,522 06 Jul 2022 Direct
Mark A. Sirgo Common stock Award 12.6% 175,000 1,560,428 01 Jul 2022 Direct
Samantha Ventimiglia Stock Option (Right to Buy) Award 142,509 142,509 22 Jun 2022 Direct
Yehuda Michael Rice Stock Option (Right to Buy) Award 142,509 142,509 22 Jun 2022 Direct
Constantino Michael T. Stock Option (Right to Buy) Award 142,509 142,509 22 Jun 2022 Direct
Mark A. Sirgo Stock Option (Right to Buy) Award 142,509 142,509 22 Jun 2022 Direct
Lorin K. Johnson Stock Option (Right to Buy) Award 142,509 142,509 22 Jun 2022 Direct
Constantino Michael T. Common Stock Purchase 36% $7,608 $0.4755 16,000 60,509 23 May 2022 Direct
John Temperato Common Stock Purchase 3.99% $22,285 $0.4457 50,000 1,302,522 18 May 2022 Direct
Mark A. Sirgo Common Stock Purchase 8.32% $50,000 $0.4700 106,383 1,385,428 18 May 2022 Direct
John Temperato Common stock Purchase 8.68% $55,590 $0.5559 100,000 1,252,522 03 Mar 2022 Direct
Mark A. Sirgo Common stock Purchase 7.25% $50,002 $0.5784 86,450 1,279,045 03 Mar 2022 Direct
John Temperato Stock Option (Right to Buy) Award 2,479,060 2,479,060 21 Feb 2022 Direct
Bethany Sensenig Stock Option (Right to Buy) Award 1,300,000 1,300,000 18 Jan 2022 Direct
Mark A. Sirgo Common Stock Purchase 4.19% $44,500 $0.8900 50,000 1,242,595 02 Dec 2021 Direct
John Temperato Common stock Purchase 4.54% $52,500 $1.05 50,000 1,152,522 18 Nov 2021 Direct
Mark A. Sirgo Common stock Purchase 1.71% $21,200 $1.06 20,000 1,192,595 18 Nov 2021 Direct
Samantha Ventimiglia Stock Option (Right to Buy) Award 150,000 150,000 01 Oct 2021 Direct
Edward J. Sitar Common stock Purchase 8.36% 15,000 194,338 14 Sep 2021 Direct
Mark A. Sirgo Common stock Purchase 6.69% $99,999 $1.36 73,529 1,172,595 07 Sep 2021 Direct
Constantino Michael T. Common stock Purchase 52.8% 18,000 52,108 24 Aug 2021 Direct
Mark A. Sirgo Common stock Purchase 2.33% $27,500 $1.10 25,000 1,099,066 20 Aug 2021 Direct
John Temperato Common stock Purchase 2.32% $26,250 $1.05 25,000 1,102,522 18 Aug 2021 Direct
OrbiMed Israel GP Ltd. Common Stock Sale -65.1% -15,989,876 8,565,974 25 Jun 2021 See Footnotes
OrbiMed Israel GP Ltd. Common Stock Sale -1.28% -319,255 24,555,850 24 Jun 2021 See Footnotes
OrbiMed Israel GP Ltd. Common Stock Sale -3.27% -841,650 24,875,105 23 Jun 2021 See Footnotes
Constantino Michael T. Stock Option (Right to Buy) Award 90,000 90,000 22 Jun 2021 Direct
Mark A. Sirgo Stock Option (Right to Buy) Award 90,000 90,000 22 Jun 2021 Direct
Lorin K. Johnson Stock Option (Right to Buy) Award 90,000 90,000 22 Jun 2021 Direct
OrbiMed Israel GP Ltd. Common Stock Exercise of in-the-money or at-the-money derivative security 0.05% 12,500 25,729,255 11 May 2021 See Footnotes
OrbiMed Israel GP Ltd. Common Stock Exercise of in-the-money or at-the-money derivative security 0.08% 19,444 25,748,699 11 May 2021 See Footnotes (1)(2
OrbiMed Israel GP Ltd. Stock Option (right to buy) Exercise of in-the-money or at-the-money derivative security 65.7% 31,944 80,556 11 May 2021 See Footnotes
Constantino Michael T. Common stock Purchase $20,001 $0.7545 26,509 26,509 20 Aug 2020 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.